Compare
Astrana Health vs Encompass Health (ASTH vs EHC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Astrana Health (ASTH) returned +3.8% and Encompass Health (EHC) +19.3%; so far this year the figures are +39.1% and +29.6%.
Encompass Health is the larger company by market value, about 7.0 times the size of Astrana Health.
On trailing earnings, ASTH trades at 31.9 times and EHC at 21.5 times.
Revenue grew +35.1% at ASTH and +9.4% at EHC over the last year.
ASTH pays no dividend. EHC yields 0.41%.
Data as of the latest close. Not investment advice.
Relative performance
| ASTH | EHC | |
|---|---|---|
| Price | $34.50 | $137.54 |
| 1-day | -11.56% | -2.64% |
| YTD | +39.06% | +29.58% |
| 1 year | +3.79% | +19.29% |
| 3 years | +13.82% | +119.85% |
| Market cap | $1.9B | $13.5B |
| P/E | 31.9 | 21.5 |
| P/S | 0.49 | 2.13 |
| P/B | 2.25 | 5.03 |
| Revenue growth | +35.10% | +9.40% |
| EPS growth | +440.00% | +21.00% |
| Gross margin % | 11.0 | — |
| Net margin % | 1.4 | 10.2 |
| ROE % | 6.2 | 24.0 |
| Debt / equity | 1.08 | 0.97 |
| FCF yield % | 5.2 | 3.4 |
| Dividend yield % | — | 0.41 |
| Beta | 0.59 | -0.04 |
| RSI (14) | 39.8 | 63.7 |
| Technical rating |